WO2008091032A1 - Atopy eczema relaxant composition using natural material - Google Patents

Atopy eczema relaxant composition using natural material Download PDF

Info

Publication number
WO2008091032A1
WO2008091032A1 PCT/KR2007/000548 KR2007000548W WO2008091032A1 WO 2008091032 A1 WO2008091032 A1 WO 2008091032A1 KR 2007000548 W KR2007000548 W KR 2007000548W WO 2008091032 A1 WO2008091032 A1 WO 2008091032A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
atopic eczema
powder
composition
atopic
Prior art date
Application number
PCT/KR2007/000548
Other languages
French (fr)
Inventor
Soo-Jeong Jin
Sam-Dong Cho
Dong-Won Kim
Jung-Jin Choi
Original Assignee
Dong Yang Living Quest Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Yang Living Quest Co., Ltd. filed Critical Dong Yang Living Quest Co., Ltd.
Publication of WO2008091032A1 publication Critical patent/WO2008091032A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Definitions

  • the present invention relates to an atopic eczema(atopy eczema) relaxant composition formed from natural plants and minerals that relaxes atopic eczema when applied to skin, and more particularly, to an atopic eczema relaxant composition using natural material which inhibits and relaxes atopic eczema symptoms by emitting large quantities of negative ions to negatively ionize ozone molecules (which promote atopic eczema), which moisturizes atopic skin, and which provides monovalence to atopic areas, and to a manufacturing method of the atopic eczema relaxant composition.
  • Atopic eczema is a skin ailment that can be triggered by various pollutants or bacteria such as staphylococcus which cause skin to overreact, and usually occurs in inherently dry skin or in skin that becomes dry.
  • staphylococcus which cause skin to overreact, and usually occurs in inherently dry skin or in skin that becomes dry.
  • ⁇ 3> There are many causes that trigger atopic eczema or worsen the condition. Not only is there an increase in cases accompanying an increase in ozone concentration in the atmosphere, but there is also a rise in the severity in patients' symptoms. Thus, it is widely believed that the ozone in the atmosphere is contributing to the rise in atopic eczema cases and severely worsening the symptoms in existing patients.
  • Ozone in the atmosphere is a secondary pollutant that is generated when pollutants such as automobile and industrial emissions undergo a photochemical reaction with sunlight.
  • pollutants such as automobile and industrial emissions undergo a photochemical reaction with sunlight.
  • industrial and economic development is causing a rise in the numbers of atopic eczema patients.
  • ⁇ 5> Specifically, the number of atopic eczema cases in urban areas is significantly greater than in rural areas, and the number of pediatric atopic eczema cases requiring hospitalization rises by 73% with each increase of 50 ppb in atmospheric ozone levels.
  • patients who require hospitalization are those suffering from severe cases of atopic eczema, and the increase in the number of patients suffering from milder cases of atopic eczema that do not require hospitalization is estimated to be much greater than the increase in severe cases requiring hospitalization.
  • atopic eczema patients can be prevented from being exposed to ozone, their atopic eczema symptoms can significantly be lessened or cured.
  • preventing an atopic eczema patient from being exposed to ozone means preventing the patient from exposure to air, which can not only be ineffective in relieving or curing atopic eczema symptoms, but can also trigger other skin ailments.
  • Ozone that is generated from automotive and industrial pollutants can be divided into cation ozone and anion ozone, the former of which is responsible for inducing atopic eczema in skin.
  • ⁇ 9> Accordingly, by preventing exposure of an atopic eczema patient to only cation ozone or by converting the entirety of ozone that an atopic eczema patient is exposed to to anion ozone, the patient's atopic eczema symptoms can be significantly reduced or cured. Also, by converting the entirety of ozone molecules, to which an atopy eczema patient is exposed, to anion ozone and moisturizing the patient's skin at the same time, the positive effects of such treatment can be two-fold and provide a treatment that significantly reduces the atopic eczema symptoms or cures the ailment.
  • compositions are being developed for treating and curing atopic eczema of the skin using plant, mineral, and other natural ingredients or ingredients that are not harmful to the human body. Because the compositions that are being developed commonly do not have the function of converting ozone (that aggravates atopic eczema on skin) to anion ions, the compositions are limited in their inability to completely eradicate atopic eczema symptoms.
  • Korean Patent Publication No. 10-2002-46329 published on June 21st, 2002, which is hereby incorporated by reference, proposes a composition of a natural anion surfactant, high-grade alcohol, moisturizer, anti-inflammatory agents, and itch preventing ingredients to be used as a topical remedy for atopic eczema.
  • Korean Patent Publication No. 10-2004-46776 published on June 5th, 2004, which is hereby incorporated by reference, proposes a composition for improving atopic skin, which includes natrium silicate, castor oil, calcium chloride, magnesium sulfate, and purified water.
  • composition for improving atopic skin has the effects of improving atopic eczema skin conditions for live cell metabolism, it lacks the ability to moisturize skin and convert ozone molecules that cause atopic eczema to anion ozone, and thus has limits in treating atopic eczema.
  • Korean Patent Publication No. 10-2005-121107 published on December 26th, 2005, which is hereby incorporated by reference, proposes an applicable composition for treating atopy, which mixes an oil having doxepin hydrochloride dissolved therein with water and homogenizes it, whereby the doxepin hydrochloride is the active ingredient.
  • This applicable composition for treating atopic skin with doxepin hydrochloride as the active ingredient provides moisturizing of skin to treat atopic ailments.
  • this applicable composition for treating atopic ailments uses doxepin hydrochloride as the main active ingredient, it can cause side effects, and the composition is also incapable of converting ozone molecules that cause atopic eczema to anion ozone, so that there is a limit to its effectiveness in treating atopic eczema.
  • Korean Patent Publication No. 10-2006-72673 published on June 28th, 2006, which is hereby incorporated by reference, proposes an applicable composition for treating atopic skin that uses Chinese juniper leaf extract as the main ingredient.
  • This applicable skin treatment composition for atopic eczema has a certain level of effectiveness in treating atopy with the Chinese medicinal properties in the Chinese juniper leaf extract. However, because it lacks the ability to moisturize skin and convert ozone molecules that contribute to atopic eczema of skin to anion ozone, it is limited in its ability to cure atopic eczema.
  • Korean Patent Publication No. 10-2006-118809 published on November 24th, 2006, which is hereby incorporated by reference, proposes a composition for treating atopic skin that includes a mixture of various botanical products such as cassia seed, nothosmyrnium root, teucrium veronicoides maxim, and balloon flower.
  • This skin treatment composition for atopic eczema with botanical products is capable of relaxing overreaction of skin through the botanical products and has a certain degree of effectiveness in treating atopic eczema.
  • it lacks the ability to convert ozone molecules that contribute to atopic eczema of skin to anion ozone, and is thus limited in its ability to cure atopic eczema.
  • This composition of bathing additives for treating atopic cases caused by dry skin from low blood levels and the pouch for holding the additives can treat skin dryness caused by low bodily blood levels to a certain degree.
  • it cannot convert ozone molecules that cause atopic eczema to anion ozone, and can only be used during bathing, limiting its usage.
  • the effects of its dry skin treatment are temporally restricted.
  • Korean Patent Publication No. 10-2002-61964 published on July 14th, 2002, which is hereby incorporated by reference, proposes edible atopic eczema treatment liquid extracts from blue peri 11a leaf red peri 11a leaf, and salt.
  • the present invention provides an atopic eczema relaxant composition formed from natural plants and minerals that converts ozone molecules which advance atopic eczema to anion ozone, moisturizes areas affected by atopic eczema, and provides resistance to staphylococcus bacteria that causes atopy, in order to reduce atopic eczema symptoms of skin and cure the disease.
  • an atopic eczema relaxant composition including: 100 parts by weight of alkaline ionized water; 25 to 35 parts by weight of a natural mineral powder with a grain size of 10,000 mesh, selected from a group consisting of sericite and kiyoseki ; 35 to 45 parts by weight of pine needle powder with a grain size of 10,000 mesh; 0.5 to 1 part by weight of anti-bacterial powder with a grain size of 4,000 mesh; 7 to 12 parts by weight of green tea leaf powder; 0.5 to 1 part by weight of onion peel powder; and 0.5 to 1 part by weight of ethanol .
  • the atopic eczema relaxant composition using natural ingredients according to the present invention moisturizes atopic skin and emits large quantities of negative ions that negatively ionize ozone molecules which contribute to atopic eczema, so that atopic eczema is alleviated.
  • the atopic eczema relaxing composition using natural ingredients according to the present invention uses an alkaline solvent mixed with natural mineral powder, anti-bacterial powder, onion peel powder, green tea leaf powder, ethanol, and carrot liquid extract, which are selected from the group including pine needle powder, sericite, and kiyoseki .
  • composition that is an atopic eczema relaxant uses alkaline ionized water as a liquid extract in which various ingredients are dissolved.
  • electrolysis is performed on water, electrically charged alkaline ionized water and acidic ionized water with positively charged ions is separated, and the alkaline ionized water is used as a solvent in order to increase the level of emitted anion ions from the atopic eczema relaxant composition of the present invention.
  • This alkaline ionized water is able to raise the natural immunity level in a human body by combining with harmful oxygen (active oxygen) generated from inside the body to dispel the harmful oxgyen from the body, and also generates energy to withdraw other waste products from the body.
  • harmful oxygen active oxygen
  • ⁇ 3i> Water exists in a state where its molecules are not uniformly arranged, but are clustered together, so that when the size of the clusters of water molecules are reduced, the ability of water to infiltrate the body increases.
  • the size of water molecule clusters can be measured using a nuclear magnetic resonance measuring device.
  • a nuclear magnetic resonance measuring device is used to measure the molecular clusters of common tap water
  • the size of tap water molecular clusters are 120 Hz; however, the size of human cells are 60 Hz.
  • tap water molecules it is very difficult for tap water molecules to penetrate human cells.
  • the present invention cannot employ tap water or tap water purified a plurality of times in the atopic eczema relaxant composition.
  • the above-described alkaline ionized water that is charged with a large quantity of negative ions so that it has molecular clusters of 54 Hz (which is smaller than human cells) is used as a solvent, so that the atopic eczema relaxant composition is highly capable of penetrating human skin and thus, is highly effective in moisturizing human skin.
  • This atopic eczema relaxant composition includes: 100 parts by weight of alkaline ionized water; 25 to 35 parts by weight of a natural mineral powder with a grain size of 10,000 mesh, selected from a group consisting of sericite and kiyoseki ; 35 to 45 parts by weight of pine needle powder with a grain size of 10,000 mesh; 0.5 to 1 part by weight of anti-bacterial powder with a grain size of 4,000 mesh; 7 to 12 parts by weight of green tea leaf powder; 0.5 to 1 part by weight of onion peel powder; and 0.5 to 1 part by weight of ethanol .
  • an atopic eczema relaxant composition using natural materials according to the present invention includes a natural mineral powder that is made from the groups sericite or kiyoseki .
  • Sericite that is included in an atopic eczema relaxant composition using natural materials, is a silver-white type of clay material that exhibits a silky luster. In minerology, it is in the mica group, resembling white mica in terms of chemical composition and crystal structure, and emits large quantities of far-infrared rays and negative ions, and has the characteristic of being able to absorb various harmful materials.
  • the far- infrared radiation generated by sericite is able to deeply penetrate the human body from 30 to 50 mm.
  • the sericite promotes blood circulation and discharging of cell waste products and harmful heavy metals through perspiration. Thus, sericite promotes a regular metabolism within the body and improves the natural healing capacity of the body so that shoulder pain, back pain, rheumatism, etc. can be treated. Also, sericite may be used to compliment various conventional treatment methods.
  • Kiyoseki As a mineral that was formed 6,500 years ago through diastrophism and the effects of hot water, kiyoseki emits large quantities of far-infrared rays to warm human cells and increase blood circulation, and promotes the metabolism to activate cells. Kiyoseki emits large quantities of negative ions to break up clusters of water molecules into smaller segments, so that inflow and outflow of water is aided, as is emulsion of oil content, and aids hair growth and maintenance. Water, of which molecular clusters have been broken up by negative ions emitted from Kiyoseki, is easily absorbed into the human body and activated, and effectively moisturizes skin by supplying ample amounts of moisture to skin.
  • an atopic eczema relaxant composition using natural materials is formed to include ultra-fine sericite and kiyoseki powder of 10,000 mesh that is produced by nano grinding at a high speed of 7,000 rpm in a nano grinder .
  • the atopic eczema relaxant composition including natural mineral powder selected from sericite and kiyoseki that is ground to an ultra-fine grain size of 10,000 mesh tightly adheres to ozone molecules in the air to convert the ozone molecules to anion ozone.
  • Pine needles include an abundancy of terpene-type phytoncide (which in itself emits negative ions), and is an ingredient that has large quantities of vitamins and minerals beneficial to the human body. Also, pine needles provide the atopic eczema relaxant composition using natural ingredients with a pleasant pine scent that raises user satisfaction.
  • pine needles are washed thoroughly, dried through natural evaporation, and ground to an ultra-fine powder with particles of 10,000 mesh that is produced by nano grinding at a high speed of 7,000 rpm in a nano grinder.
  • anti-bacterial powder of 4,000 mesh that provides resistance against staphylococcus and various other bacteria, is included in the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
  • ⁇ 5i> The greater the surface area per weight unit (or the finer the size of powder particles) of the ant i-bacterial powder is, the greater the contact between the anti-bacterial powder with air and skin is, and the greater the effect against bacteria there is. Specifically, given two quantities of anti-bacterial powder that are identical in weight but different in particle size, because the quantity with the finer powder particles provides a wider surface area that contacts air and skin than the quantity with coarser particles, the finer powder is more effective at opposing staphylococcus and various other bacteria.
  • the anti-bacterial material of the present invention is ground to a powder with a grain size of 4,000 mesh through a 5,000 rpm high ⁇ speed nano grinding using a nano grinder.
  • Green tea has large quantities of catechin, it is effective in preventing various diseases such as cancer and in disinfecting. Green tea also has ample quantities of vitamins C and E, beta carotine, plant fibers, minerals, and chlorophyl.
  • 0.5 to 1 part by weight of onion peel powder is added to 100 parts by weight of alkaline ionized water to form the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
  • Onion peel contains allicin that has the properties of disinfecting and inhibiting fungi, and is the most effective natural edible anti-fungal agent known. Therefore, by incorporating onion peel into the atopic eczema relaxant composition, fungus removal can be realized without having to resort to chemical anti-fungal agents.
  • ⁇ 60> Further, 0.5 to 1 part by weight of ethanol is added to 100 parts by weight of alkaline ionized water to preserve the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
  • the ethanol used in the composition may be natural ethanol derived from fermenting plant material, so that there are no health side effects on users from ethanol wastes.
  • Carrots contain ample amounts of beta carotine (vitamin A), which disables carcinogens and poisonous substances and is a strong antioxidant that prevents harmful oxygen from damaging cells. Also, carrots are known in Chinese medicine to strengthen the heart and stomach and benefit the lungs.
  • vitamin A beta carotine
  • composition with the above ingredients is agitated for a duration of 110 to 130 minutes at a temperature of 80 to 90°C to jellify, and is quickly cooled to room temperature and cured for 120 minutes, so that it becomes a gelatinous completed atopic eczema relaxant composition.
  • atopic eczema relaxant composition using the above natural ingredients When the atopic eczema relaxant composition using the above natural ingredients is applied to atopic skin or skin with atopic eczema, it converts ozone contacting the skin to anion ozone to relax atopic eczema symptoms.
  • the atopic eczema relaxant composition according to the present invention includes ultra-fine sericite and kiyoseki powder ground to a particle size of 10,000 mesh so that the surface area of the sericite and kiyoseki contacting ozone molecules in the atmosphere is large, the composition is very effective at converting ozone molecules to anion ozone.
  • An advantage of the atopic eczema relaxant composition using natural ingredients according to the present invention is that it emits large quantities of negative ions that convert ozone molecules (which contribute to atopic eczema) to anion ozone, moisturizes atopic skin, and provides bacterial resistance to atopic areas of skin, so that atopic eczema symptoms are generally suppressed and relaxed.
  • atopic eczema relaxant composition using natural ingredients according to the present invention is that it continuously emits the natural scent of pine, increasing user satisfaction.
  • a further advantage of the atopic eczema relaxant composition using natural ingredients according to the present invention is that its manufacturing process is simple, thereby reducing its cost.
  • Sericite is ground to a powder at a high speed of 7,000 rpm in a nano grinder to yield a particle size of 10,000 mesh.
  • pine needles are washed, naturally dried until there is no moisture on their surfaces, and then the dried pine needles are ground to a powder at a high speed of 7,000 rpm in a nano grinder to yield a particle size of 10,000 mesh.
  • a composition is formed by mixing 1,000 g of alkaline ionized water, 300 g of sericite powder of 10,000 mesh, 400 g of pine needle powder of 10,000 mesh, 50 g of anti-bacterial powder of 4,000 mesh, 100 g of green tea leaf powder, 5 g of onion peel powder, 5 g of natural ethanol, and 5 g of carrot extract in a reactor capable of recirculating evaporating liquids.
  • the composition is agitated at 500 rpm for 120 minutes at 85°C and jellified, and alkaline ionized water that evaporates is recovered and reintroduced to the jellified composition.
  • the jellified composition is rapidly cooled to room temperature in a rapid cooler.
  • the rapidly cooled gel is cured at room temperature for 120 hours to produce a yellowish-silver atopic eczema relaxant composition.
  • the atopic eczema relaxant composition of the present invention converts ozone (that comes into contact with skin having atopic eczema) to anion ozone, which does not adversely affect atopic eczema symptoms.
  • the atopic eczema relaxant composition using natural materials according to the present invention emits large quantities of negative ions and far-infrared rays to convert ozone (which promotes atopic eczema symptoms) to anion ozone (which does not agitate atopic eczema symptoms), so that atopic eczema symptoms can be treated and relieved.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an atopic eczema relaxant composition formed from natural plants and minerals that relaxes atopic eczema when applied to skin. The atopic eczema relaxant composition includes 100 parts by weight of alkaline ionized water, 25 to 35 parts by weight of natural mineral powder with a grain size of 10,000 mesh, selected form a group consisting of sericite and kiyoseki, 35 to 45 parts by weight of pine needle powder with a grain size of 10,000 mesh, 1 part by weight of anti-bacterial powder with a grain size of 4,000 mesh, 7 to 12 parts by weight of green tea leaf powder, 0.5 to 1 part by weight of onion peel powder, and 0.5 to 1 part by weight of ethanol. The atopic eczema relaxant composition using natural ingredients emits large quantities of negative ions that convert ozone molecules (which contribute to atopic eczema) to anion ozone, moisturizes atopic skin, and provides bacterial resistance to atopic areas of skin, so that atopic eczema symptoms are generally suppressed and relaxed.

Description

[DESCRIPTION]
[Invention Title]
ATOPY ECZEMA RELAXANT COMPOSITION USING NATURAL MATERIAL
[Technical Field]
<i> The present invention relates to an atopic eczema(atopy eczema) relaxant composition formed from natural plants and minerals that relaxes atopic eczema when applied to skin, and more particularly, to an atopic eczema relaxant composition using natural material which inhibits and relaxes atopic eczema symptoms by emitting large quantities of negative ions to negatively ionize ozone molecules (which promote atopic eczema), which moisturizes atopic skin, and which provides monovalence to atopic areas, and to a manufacturing method of the atopic eczema relaxant composition.
[Background Art]
<2> There has been a sharp rise recently in the number of atopy or eczema (atopic eczema) patients, especially in child sufferers of atopic eczema, who have skin that is weak or has low immunity, and an increase in the severity of cases. Atopic eczema is a skin ailment that can be triggered by various pollutants or bacteria such as staphylococcus which cause skin to overreact, and usually occurs in inherently dry skin or in skin that becomes dry. <3> There are many causes that trigger atopic eczema or worsen the condition. Not only is there an increase in cases accompanying an increase in ozone concentration in the atmosphere, but there is also a rise in the severity in patients' symptoms. Thus, it is widely believed that the ozone in the atmosphere is contributing to the rise in atopic eczema cases and severely worsening the symptoms in existing patients.
<4> Ozone in the atmosphere is a secondary pollutant that is generated when pollutants such as automobile and industrial emissions undergo a photochemical reaction with sunlight. Thus, industrial and economic development is causing a rise in the numbers of atopic eczema patients. <5> Specifically, the number of atopic eczema cases in urban areas is significantly greater than in rural areas, and the number of pediatric atopic eczema cases requiring hospitalization rises by 73% with each increase of 50 ppb in atmospheric ozone levels. Here, patients who require hospitalization are those suffering from severe cases of atopic eczema, and the increase in the number of patients suffering from milder cases of atopic eczema that do not require hospitalization is estimated to be much greater than the increase in severe cases requiring hospitalization.
<6> Furthermore, because there are multiple documented reports stating that patients with moderately severe atopic eczema who were treated in rural environments have been completely cured or have had their atopic symptoms subside to an outwardly invisible level, it is widely accepted that ozone is a prominent propagator of atopic eczema symptoms.
<7> Thus, theoretically, if atopic eczema patients can be prevented from being exposed to ozone, their atopic eczema symptoms can significantly be lessened or cured. In practice, however, preventing an atopic eczema patient from being exposed to ozone means preventing the patient from exposure to air, which can not only be ineffective in relieving or curing atopic eczema symptoms, but can also trigger other skin ailments.
<8> Ozone that is generated from automotive and industrial pollutants can be divided into cation ozone and anion ozone, the former of which is responsible for inducing atopic eczema in skin.
<9> Accordingly, by preventing exposure of an atopic eczema patient to only cation ozone or by converting the entirety of ozone that an atopic eczema patient is exposed to to anion ozone, the patient's atopic eczema symptoms can be significantly reduced or cured. Also, by converting the entirety of ozone molecules, to which an atopy eczema patient is exposed, to anion ozone and moisturizing the patient's skin at the same time, the positive effects of such treatment can be two-fold and provide a treatment that significantly reduces the atopic eczema symptoms or cures the ailment.
<io> Because the rise in dermatologic atopic eczema cases and the increase in the severity of cases brought about by urbanization and industrialization has become a societal issue, compounds are being developed for treating and curing atopic eczema of the skin using plant, mineral, and other natural ingredients or ingredients that are not harmful to the human body. Because the compositions that are being developed commonly do not have the function of converting ozone (that aggravates atopic eczema on skin) to anion ions, the compositions are limited in their inability to completely eradicate atopic eczema symptoms.
<ii> For example, Korean Patent Publication No. 10-2002-46329, published on June 21st, 2002, which is hereby incorporated by reference, proposes a composition of a natural anion surfactant, high-grade alcohol, moisturizer, anti-inflammatory agents, and itch preventing ingredients to be used as a topical remedy for atopic eczema.
<12> While this topical composition for reducing atopic eczema symptoms has the capability of improving atopic skin, it is ineffective at converting the ozone molecules that cause atopic eczema to anion ozone, and thus has limits in treating atopic eczema.
<i3> Also, Korean Patent Publication No. 10-2004-46776, published on June 5th, 2004, which is hereby incorporated by reference, proposes a composition for improving atopic skin, which includes natrium silicate, castor oil, calcium chloride, magnesium sulfate, and purified water.
<14> Although this composition for improving atopic skin has the effects of improving atopic eczema skin conditions for live cell metabolism, it lacks the ability to moisturize skin and convert ozone molecules that cause atopic eczema to anion ozone, and thus has limits in treating atopic eczema.
<i5> Furthermore, Korean Patent Publication No. 10-2005-121107, published on December 26th, 2005, which is hereby incorporated by reference, proposes an applicable composition for treating atopy, which mixes an oil having doxepin hydrochloride dissolved therein with water and homogenizes it, whereby the doxepin hydrochloride is the active ingredient.
<16> This applicable composition for treating atopic skin with doxepin hydrochloride as the active ingredient provides moisturizing of skin to treat atopic ailments. However, because this applicable composition for treating atopic ailments uses doxepin hydrochloride as the main active ingredient, it can cause side effects, and the composition is also incapable of converting ozone molecules that cause atopic eczema to anion ozone, so that there is a limit to its effectiveness in treating atopic eczema.
<i7> Additionally, Korean Patent Publication No. 10-2006-72673, published on June 28th, 2006, which is hereby incorporated by reference, proposes an applicable composition for treating atopic skin that uses Chinese juniper leaf extract as the main ingredient.
<i8> This applicable skin treatment composition for atopic eczema has a certain level of effectiveness in treating atopy with the Chinese medicinal properties in the Chinese juniper leaf extract. However, because it lacks the ability to moisturize skin and convert ozone molecules that contribute to atopic eczema of skin to anion ozone, it is limited in its ability to cure atopic eczema.
<19> Also, Korean Patent Publication No. 10-2006-118809, published on November 24th, 2006, which is hereby incorporated by reference, proposes a composition for treating atopic skin that includes a mixture of various botanical products such as cassia seed, nothosmyrnium root, teucrium veronicoides maxim, and balloon flower.
<20> This skin treatment composition for atopic eczema with botanical products is capable of relaxing overreaction of skin through the botanical products and has a certain degree of effectiveness in treating atopic eczema. However, it lacks the ability to convert ozone molecules that contribute to atopic eczema of skin to anion ozone, and is thus limited in its ability to cure atopic eczema.
<2i> Besides the above-described applicable compositions, Korean Patent Publication No. 10-2006-33608, published on April 19th, 2006, which is hereby incorporated by reference, proposes a composition for adding to bath water and a pouch for holding the composition, which includes mung bean powder, white aconite root, blepilla striata, marsdenia longpipes, and various other Chinese medicinal ingredients, for atopic cases caused by dry skin due to low blood levels.
<22> This composition of bathing additives for treating atopic cases caused by dry skin from low blood levels and the pouch for holding the additives can treat skin dryness caused by low bodily blood levels to a certain degree. However, it cannot convert ozone molecules that cause atopic eczema to anion ozone, and can only be used during bathing, limiting its usage. Thus, from a user's perspective, the effects of its dry skin treatment are temporally restricted.
<23> Further, Korean Patent Publication No. 10-2002-61964, published on July 14th, 2002, which is hereby incorporated by reference, proposes edible atopic eczema treatment liquid extracts from blue peri 11a leaf red peri 11a leaf, and salt.
<24> Although this edible treatment for atopic eczema provides some results in curing atopic eczema symptoms, it has the drawback of being incapable of local application to skin areas affected with atopic eczema. [Disclosure] [Technical Problem]
<25> To solve the above problem, the present invention provides an atopic eczema relaxant composition formed from natural plants and minerals that converts ozone molecules which advance atopic eczema to anion ozone, moisturizes areas affected by atopic eczema, and provides resistance to staphylococcus bacteria that causes atopy, in order to reduce atopic eczema symptoms of skin and cure the disease. [Technical Solution]
<26> According to an aspect of the present invention, there is provided an atopic eczema relaxant composition including: 100 parts by weight of alkaline ionized water; 25 to 35 parts by weight of a natural mineral powder with a grain size of 10,000 mesh, selected from a group consisting of sericite and kiyoseki ; 35 to 45 parts by weight of pine needle powder with a grain size of 10,000 mesh; 0.5 to 1 part by weight of anti-bacterial powder with a grain size of 4,000 mesh; 7 to 12 parts by weight of green tea leaf powder; 0.5 to 1 part by weight of onion peel powder; and 0.5 to 1 part by weight of ethanol .
<27> The atopic eczema relaxant composition using natural ingredients according to the present invention moisturizes atopic skin and emits large quantities of negative ions that negatively ionize ozone molecules which contribute to atopic eczema, so that atopic eczema is alleviated.
<28> Reference will now be made in detail to the preferred embodiments of the atopic eczema relaxant composition using natural ingredients according to the present invention.
<29> The atopic eczema relaxing composition using natural ingredients according to the present invention uses an alkaline solvent mixed with natural mineral powder, anti-bacterial powder, onion peel powder, green tea leaf powder, ethanol, and carrot liquid extract, which are selected from the group including pine needle powder, sericite, and kiyoseki .
<30> The above-described composition that is an atopic eczema relaxant uses alkaline ionized water as a liquid extract in which various ingredients are dissolved. When electrolysis is performed on water, electrically charged alkaline ionized water and acidic ionized water with positively charged ions is separated, and the alkaline ionized water is used as a solvent in order to increase the level of emitted anion ions from the atopic eczema relaxant composition of the present invention. This alkaline ionized water is able to raise the natural immunity level in a human body by combining with harmful oxygen (active oxygen) generated from inside the body to dispel the harmful oxgyen from the body, and also generates energy to withdraw other waste products from the body.
<3i> Water exists in a state where its molecules are not uniformly arranged, but are clustered together, so that when the size of the clusters of water molecules are reduced, the ability of water to infiltrate the body increases.
<32> Specifically, the size of water molecule clusters can be measured using a nuclear magnetic resonance measuring device. When a nuclear magnetic resonance measuring device is used to measure the molecular clusters of common tap water, the size of tap water molecular clusters are 120 Hz; however, the size of human cells are 60 Hz. Thus, it is very difficult for tap water molecules to penetrate human cells. Since it is difficult for tap water molecules to penetrate human cells to moisturize human skin, the present invention cannot employ tap water or tap water purified a plurality of times in the atopic eczema relaxant composition.
<33> However, when water is subjected to electrolysis to electrically charge it with a large quantity of negative ions, the sizes of molecular clusters are reduced. Accordingly, alkaline ionized water that is charged with a large quantity of negative ions so that it has molecular clusters of 54 Hz (which is smaller than human cells) is used as an ingredient in the atopic eczema relaxant composition. The above-described alkaline ionized water that is charged with a large quantity of negative ions so that it has molecular clusters of 54 Hz (which is smaller than human cells) is used as a solvent, so that the atopic eczema relaxant composition is highly capable of penetrating human skin and thus, is highly effective in moisturizing human skin.
<34> Also, the solvent that is alkaline ionized water, electrically charged with a large quantity of negative ions to have a cluster size of 54 Hz, is mixed with negative ions, natural mineral powder that emits far-infrared rays, and pine needle powder to produce a synergetic atopic eczema relaxant composition that is highly effective in emitting negative ions.
<35> This atopic eczema relaxant composition includes: 100 parts by weight of alkaline ionized water; 25 to 35 parts by weight of a natural mineral powder with a grain size of 10,000 mesh, selected from a group consisting of sericite and kiyoseki ; 35 to 45 parts by weight of pine needle powder with a grain size of 10,000 mesh; 0.5 to 1 part by weight of anti-bacterial powder with a grain size of 4,000 mesh; 7 to 12 parts by weight of green tea leaf powder; 0.5 to 1 part by weight of onion peel powder; and 0.5 to 1 part by weight of ethanol .
<36> First, one embodiment of an atopic eczema relaxant composition using natural materials according to the present invention includes a natural mineral powder that is made from the groups sericite or kiyoseki .
<37> Sericite, that is included in an atopic eczema relaxant composition using natural materials, is a silver-white type of clay material that exhibits a silky luster. In minerology, it is in the mica group, resembling white mica in terms of chemical composition and crystal structure, and emits large quantities of far-infrared rays and negative ions, and has the characteristic of being able to absorb various harmful materials. The far- infrared radiation generated by sericite is able to deeply penetrate the human body from 30 to 50 mm. The sericite promotes blood circulation and discharging of cell waste products and harmful heavy metals through perspiration. Thus, sericite promotes a regular metabolism within the body and improves the natural healing capacity of the body so that shoulder pain, back pain, rheumatism, etc. can be treated. Also, sericite may be used to compliment various conventional treatment methods.
<38> As a mineral that was formed 6,500 years ago through diastrophism and the effects of hot water, kiyoseki emits large quantities of far-infrared rays to warm human cells and increase blood circulation, and promotes the metabolism to activate cells. Kiyoseki emits large quantities of negative ions to break up clusters of water molecules into smaller segments, so that inflow and outflow of water is aided, as is emulsion of oil content, and aids hair growth and maintenance. Water, of which molecular clusters have been broken up by negative ions emitted from Kiyoseki, is easily absorbed into the human body and activated, and effectively moisturizes skin by supplying ample amounts of moisture to skin.
<39> In the present invention, only one of sericite and Kiyoseki powder may be used to form the natural mineral ingredient, or both minerals may be used to form the natural mineral ingredient.
<40> The greater the surface area per weight unit of natural mineral powder (that is, the finer the size of powder particles), the larger the surface area that contacts air becomes, thereby increasing the negative ionization of ozone and the moisturizing effects. That is, when comparing two quantities of natural mineral powder that are identical in weight but different in particle size, because the quantity with the finer powder particles is more likely to contact more ozone molecules in the atmosphere overall than the quantity with coarser particles, the finer powder is more effective at converting ozone molecules to anion ozone.
<4i> Therefore, an atopic eczema relaxant composition using natural materials is formed to include ultra-fine sericite and kiyoseki powder of 10,000 mesh that is produced by nano grinding at a high speed of 7,000 rpm in a nano grinder .
<42> The atopic eczema relaxant composition including natural mineral powder selected from sericite and kiyoseki that is ground to an ultra-fine grain size of 10,000 mesh tightly adheres to ozone molecules in the air to convert the ozone molecules to anion ozone.
<43> When 25 parts by weight or less of natural mineral powder is included in the composition, the effects of converting ozone to anion ozone and the moisturizing effects of the atopic eczema relaxant made from the composition are lessened; and when 35 parts by weight or more of natural mineral powder is included in the composition, the mixture becomes overly gelatinous so that the sensation of the manufactured atopic eczema relaxant composition becomes unpleasant .
<44> In order to provide the effects of emitting negative ions from the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention, ultra-fine 10,000 mesh particles of pine needle powder are included.
<45> Pine needles include an abundancy of terpene-type phytoncide (which in itself emits negative ions), and is an ingredient that has large quantities of vitamins and minerals beneficial to the human body. Also, pine needles provide the atopic eczema relaxant composition using natural ingredients with a pleasant pine scent that raises user satisfaction.
<46> The greater the surface area per weight unit (or the finer the size of powder particles) of the pine needles is, the greater the contact between the pine needle powder and air is, and the greater the conversion of ozone to anion ozone is. Specifically, given two quantities of pine needle powder that are identical in weight but different in particle size, because the quantity with the finer powder particles is more likely to contact more ozone molecules in the atmosphere overall than the quantity with coarser particles, the finer powder is more effective at converting ozone molecules to anion ozone.
<47> Therefore, pine needles are washed thoroughly, dried through natural evaporation, and ground to an ultra-fine powder with particles of 10,000 mesh that is produced by nano grinding at a high speed of 7,000 rpm in a nano grinder.
<48> The pine needle powder emitting negative ions that is ground to an ultra-fine grain size of 10,000 mesh tightly adheres to ozone molecules in the air to convert the ozone molecules to anion ozone.
<49> When 35 parts by weight or less of pine needle powder are included in the composition, the effects of converting ozone to anion ozone and the pine scent of the atopic eczema relaxant made from the composition are lessened; and when 45 parts by weight or more of pine needle powder are included in the composition, the mechanical properties of the atopic eczema relaxant composition are compromised.
<50> Furthermore, anti-bacterial powder of 4,000 mesh, that provides resistance against staphylococcus and various other bacteria, is included in the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
<5i> The greater the surface area per weight unit (or the finer the size of powder particles) of the ant i-bacterial powder is, the greater the contact between the anti-bacterial powder with air and skin is, and the greater the effect against bacteria there is. Specifically, given two quantities of anti-bacterial powder that are identical in weight but different in particle size, because the quantity with the finer powder particles provides a wider surface area that contacts air and skin than the quantity with coarser particles, the finer powder is more effective at opposing staphylococcus and various other bacteria.
<52> Accordingly, the anti-bacterial material of the present invention is ground to a powder with a grain size of 4,000 mesh through a 5,000 rpm high¬ speed nano grinding using a nano grinder.
<53> When 0.5 parts by weight or less of anti-bacterial powder are included in the composition, the effects of the atopic eczema relaxant made from the composition against ozone are lessened; and when 1 part by weight of anti¬ bacterial powder is included in the composition, the atopic eczema relaxant composition is provided with sufficient anti-bacterial properties.
<54> Additionally, 7 to 12 parts by weight of green tea leaf powder are added to 100 parts by weight of alkaline ionized water to form the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
<55> Because green tea has large quantities of catechin, it is effective in preventing various diseases such as cancer and in disinfecting. Green tea also has ample quantities of vitamins C and E, beta carotine, plant fibers, minerals, and chlorophyl.
<56> When 7 parts by weight or less of green tea leaf powder are included in the composition, the effects of the atopic eczema relaxant made from the composition to prevent diseases such as cancer and disinfect are lessened; and when 12 parts by weight of green tea leaf powder or more are included in the composition, the jellifying of the atopic eczema relaxant composition cannot be properly conducted.
<57> Also, 0.5 to 1 part by weight of onion peel powder is added to 100 parts by weight of alkaline ionized water to form the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
<58> Onion peel contains allicin that has the properties of disinfecting and inhibiting fungi, and is the most effective natural edible anti-fungal agent known. Therefore, by incorporating onion peel into the atopic eczema relaxant composition, fungus removal can be realized without having to resort to chemical anti-fungal agents.
<59> When 0.5 parts by weight or less of onion peel powder are included in the composition, the disinfecting and anti-fungal effects of the atopic eczema relaxant made from the composition are lessened; and when 1 part by weight of onion peel powder or more is included in the composition, the mechanical properties of the atopic eczema relaxant composition are compromised.
<60> Further, 0.5 to 1 part by weight of ethanol is added to 100 parts by weight of alkaline ionized water to preserve the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
<6i> The ethanol used in the composition may be natural ethanol derived from fermenting plant material, so that there are no health side effects on users from ethanol wastes.
<62> When 0.5 parts by weight or less of ethanol are included in the composition, the preservation of the atopic eczema relaxant made from the composition is compromised; and when 1 part by weight of ethanol is included in the composition, it is sufficient to adequately preserve the atopic eczema relaxant composition.
<63> In addition, 0.5 to 1 part by weight of carrot extract is added to 100 parts by weight of alkaline ionized water to antioxidize the atopic eczema relaxant composition using natural ingredients according to the first embodiment of the present invention.
<64> Carrots contain ample amounts of beta carotine (vitamin A), which disables carcinogens and poisonous substances and is a strong antioxidant that prevents harmful oxygen from damaging cells. Also, carrots are known in Chinese medicine to strengthen the heart and stomach and benefit the lungs.
<65> Thus, carrots are washed and naturally dried until all moisture from the surface evaporates; and the dried carrots are then ground and drained, and the liquid carrot extract is collected.
<66> When 0.5 parts by weight or less of carrot extract are included in the composition, the antioxidizing and detoxifying effects of the atopic eczema relaxant made from the composition decrease! and when 1 part by weight of carrot extract is included in the composition, it provides sufficient antioxidation effects of the atopic eczema relaxant composition.
<67> The composition with the above ingredients is agitated for a duration of 110 to 130 minutes at a temperature of 80 to 90°C to jellify, and is quickly cooled to room temperature and cured for 120 minutes, so that it becomes a gelatinous completed atopic eczema relaxant composition.
<68> However, during the jellifying of the composition, alkaline ionized water that evaporates is collected and reintroduced to the composition so that the ingredients of the composition are retained.
<69> As described above, since the manufacturing process of the atopic eczema relaxant composition using natural ingredients according to the present invention is simple, its manufacturing costs are low.
<70> When the atopic eczema relaxant composition using the above natural ingredients is applied to atopic skin or skin with atopic eczema, it converts ozone contacting the skin to anion ozone to relax atopic eczema symptoms.
<7i> Because the atopic eczema relaxant composition according to the present invention includes ultra-fine sericite and kiyoseki powder ground to a particle size of 10,000 mesh so that the surface area of the sericite and kiyoseki contacting ozone molecules in the atmosphere is large, the composition is very effective at converting ozone molecules to anion ozone. [Advantageous Effects]
<73> An advantage of the atopic eczema relaxant composition using natural ingredients according to the present invention is that it emits large quantities of negative ions that convert ozone molecules (which contribute to atopic eczema) to anion ozone, moisturizes atopic skin, and provides bacterial resistance to atopic areas of skin, so that atopic eczema symptoms are generally suppressed and relaxed.
<74> Another advantage of the atopic eczema relaxant composition using natural ingredients according to the present invention is that it continuously emits the natural scent of pine, increasing user satisfaction.
<75> A further advantage of the atopic eczema relaxant composition using natural ingredients according to the present invention is that its manufacturing process is simple, thereby reducing its cost.
<76> While the present invention has been described and illustrated herein with reference to the preferred embodiments thereof, it will be apparent to those skilled in the art that various modifications and variations can be made therein without departing from the spirit and scope of the invention. Thus, it is intended that the present invention covers the modifications and variations of this invention that come within the scope of the appended claims and their equivalents. [Best Mode]
<77> Below, a detailed description will be given with reference to the first embodiment of the present invention. The below embodiments are only exemplary, and the present invention should not be construed as being limited thereto.
<78> Embodiment
<79> 1. Sericite is ground to a powder at a high speed of 7,000 rpm in a nano grinder to yield a particle size of 10,000 mesh.
<80> Also, pine needles are washed, naturally dried until there is no moisture on their surfaces, and then the dried pine needles are ground to a powder at a high speed of 7,000 rpm in a nano grinder to yield a particle size of 10,000 mesh.
<81> 2. A composition is formed by mixing 1,000 g of alkaline ionized water, 300 g of sericite powder of 10,000 mesh, 400 g of pine needle powder of 10,000 mesh, 50 g of anti-bacterial powder of 4,000 mesh, 100 g of green tea leaf powder, 5 g of onion peel powder, 5 g of natural ethanol, and 5 g of carrot extract in a reactor capable of recirculating evaporating liquids.
<82> 3. The composition is agitated at 500 rpm for 120 minutes at 85°C and jellified, and alkaline ionized water that evaporates is recovered and reintroduced to the jellified composition.
<83> 4. The jellified composition is rapidly cooled to room temperature in a rapid cooler.
<84> 5. The rapidly cooled gel is cured at room temperature for 120 hours to produce a yellowish-silver atopic eczema relaxant composition.
<85> First Exemplary Test <86> A test was conducted to compare the levels of negative ion emissions of the atopic eczema relaxant composition produced through the above embodiment with the negative ion emissions of a steroid-based atopic eczema treatment of the related art.
<87> The negative ion emission test was conducted with the KICM-FIR-1042 method that is widely used by the Korea Institute of Construction Materials.
<88> The results of the negative ion emission results of the comparison between the embodiment of the present invention and the embodiment of the related art are as follows.
<89> [Table 1] <90> Comparison of Atopic Eczema Relaxant Composition Negative Ion Emissions <91>
Figure imgf000016_0001
As shown in Table 1 above, the results of the negative ion emissions test show that the atopic eczema relaxant composition of the present invention emits 350 ions/cc.
<92> Thus, by emitting a large quantity of negative ions, the atopic eczema relaxant composition of the present invention converts ozone (that comes into contact with skin having atopic eczema) to anion ozone, which does not adversely affect atopic eczema symptoms.
<93> Second Exemplary Test
<94> The method KCIM-FIR-1005 that is commonly used to measure emitted quantities of far-infrared rays was used to measure the quantity of far- infrared ray emissions from the atopic eczema relaxant composition according to the above embodiments.
<95> The results of the far-infrared ray emission quantity measurement show that the atopic eczema relaxant composition according to the present invention has a far-infrared ray emission frequency of 0.918 with a wavelenth
2 between 5 to 20 urn and an emission energy of 3.70 X 10.
<96> Thus, it can be seen that far-infrared radiation (that facilitates the conversion of ozone to anion ozone) is emitted in large amounts from the atopic eczema relaxant composition according to the present invention.
<97> As shown by the results of the first and second exemplary tests, the atopic eczema relaxant composition using natural materials according to the present invention emits large quantities of negative ions and far-infrared rays to convert ozone (which promotes atopic eczema symptoms) to anion ozone (which does not agitate atopic eczema symptoms), so that atopic eczema symptoms can be treated and relieved.

Claims

[CLAIMS] [Claim 1]
<99> An atopy eczema relaxant composition comprising-' <ioo> 100 parts by weight of alkaline ionized water; <ioi> 25 to 35 parts by weight of a natural mineral powder with a grain size of 10,000 mesh, selected from a group consisting of sericite and kiyoseki ; <iO2> 35 to 45 parts by weight of pine needle powder with a grain size of
10,000 mesh; <i03> 0.5 to 1 part by weight of ant i-bacterial powder with a grain size of
4,000 mesh;
<i04> 7 to 12 parts by weight of green tea leaf powder; <i05> 0.5 to 1 part by weight of onion peel powder; and <io6> 0.5 to 1 part by weight of ethanol.
[Claim 2]
<iO7> The atopy eczema relaxant composition of claim 1, further comprising 0.5 to 1 part by weight of carrot liquid extract.
[Claim 3]
<i08> The atopy eczema relaxant composition of claim 2, wherein the carrot liquid extract is obtained through grinding a carrot to form ground carrot, and filtering the ground carrot to collect carrot liquid that is the carrot liquid extract .
[Claim 4]
<io9> The atopy eczema relaxant composition of claim 1, wherein the alkaline ionized water is obtained through performing electrolysis on water to separate acidic ionized water.
[Claim 5]
<πo> The atopy eczema relaxant composition of claim 4, wherein the electrolysis performed on the water forms a cluster size of the alkaline ionized water of 54 Hz.
[Claim 6] <iπ> The atopy eczema relaxant composition of claim 1, wherein the natural mineral powder is obtained through nano grinding the sericite and the kiyoseki at a grinding speed of 7,000 rpm to produce an average grain size of
10,000 mesh.
[Claim 7] <ii2> The atopy eczema relaxant composition of claim 1, wherein the pine needle powder is obtained through washing and naturally drying pine needles, and nano grinding the dried pine needles at a grinding speed of 7,000 rpm to produce an average grain size of 10,000 mesh.
[Claim 8] <ii3> The atopy eczema relaxant composition of claim 1, wherein the ethanol is natural ethanol produced from fermented plant ingredients.
PCT/KR2007/000548 2007-01-25 2007-02-01 Atopy eczema relaxant composition using natural material WO2008091032A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20070007744 2007-01-25
KR10-2007-0007744 2007-01-25

Publications (1)

Publication Number Publication Date
WO2008091032A1 true WO2008091032A1 (en) 2008-07-31

Family

ID=39644596

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/000548 WO2008091032A1 (en) 2007-01-25 2007-02-01 Atopy eczema relaxant composition using natural material

Country Status (3)

Country Link
JP (1) JP2008179594A (en)
KR (1) KR100890070B1 (en)
WO (1) WO2008091032A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008131936A2 (en) * 2007-04-25 2008-11-06 Akuatech S.R.L. Highly stable electrolytic water with reduced nmr half line width
EP2082751A3 (en) * 2008-01-25 2009-09-23 Gian Battista Ceresa Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs
CN101961103A (en) * 2009-07-25 2011-02-02 铜陵市九洲天然动植物产品有限公司 Method for preparing honeyed selenium-rich pine edible powder
US8277634B2 (en) 2005-10-28 2012-10-02 Apr Nanotechnologies S.A. Electrolytic water treatment device having sintered nanoparticle coated electrode and method for making acid or basic water therewith
US8691289B2 (en) 2009-06-17 2014-04-08 Apr Nanotechnologies S.A. Methods of treating outer eye disorders using high ORP acid water and compositions thereof
IT201600103224A1 (en) * 2016-10-17 2018-04-17 Claudia Panizza PREPARATION OF THE BASIS FOR ACTIVE SUBSTANCES

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100905437B1 (en) * 2008-11-24 2009-07-02 (주)동양정밀 Composition for treating of atopic dermatitis and preparing method thereof
JP6336729B2 (en) * 2013-09-13 2018-06-06 株式会社トータルサポートサービス Cosmetic base material containing lava stone and cosmetics using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050099450A (en) * 2004-10-15 2005-10-13 조삼동 Natural mineral composition for flooring and the preparating method thereof
KR100665857B1 (en) * 2006-06-13 2007-01-09 조삼동 Method of preparing composition for diffusing aroma of pine and blocking harmful material

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153881A2 (en) * 1984-03-02 1985-09-04 The Johns Hopkins University Treatment of allergies and inflammatory conditions
JPS62111654A (en) * 1985-11-09 1987-05-22 Horiuchi:Kk Antiallergic food
JPH09124454A (en) * 1995-11-06 1997-05-13 Toru Tsukada Production of pack containing adsorptive mudstone
KR19990078667A (en) * 1999-07-23 1999-11-05 하종심 Cream for Itching Symptoms Improvement and Manufacturing Method thereof
JP3471789B2 (en) * 2000-06-14 2003-12-02 福田 光次 Allergic disease therapeutic agent and method for producing the same
JP2002173434A (en) * 2000-12-04 2002-06-21 Nitto Denko Corp Antiallergic composition
JP3545742B2 (en) * 2001-11-30 2004-07-21 ハウス食品株式会社 Soft drink
JP2004196698A (en) * 2002-12-18 2004-07-15 Okina:Kk Dentifrice
JP2006026619A (en) * 2004-07-11 2006-02-02 Michiko Nakamura Metasilicate mineral spring water (tensho hurora water) and method for producing it
KR20060080376A (en) * 2005-01-05 2006-07-10 하수용 Cosmetic composition comprising minerals and herbal extracts and process for preparing the same
JP4158984B2 (en) * 2005-03-02 2008-10-01 独立行政法人農業・食品産業技術総合研究機構 Functional food
KR100795993B1 (en) * 2005-07-28 2008-01-21 (주)비엠씨 A Cosmetic Composition for Atopian Skin
KR100643509B1 (en) * 2006-02-24 2006-11-13 주식회사 씨쓰리 Natural chlorinated composition using natural mineral and plant material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050099450A (en) * 2004-10-15 2005-10-13 조삼동 Natural mineral composition for flooring and the preparating method thereof
KR100665857B1 (en) * 2006-06-13 2007-01-09 조삼동 Method of preparing composition for diffusing aroma of pine and blocking harmful material

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277634B2 (en) 2005-10-28 2012-10-02 Apr Nanotechnologies S.A. Electrolytic water treatment device having sintered nanoparticle coated electrode and method for making acid or basic water therewith
WO2008131936A2 (en) * 2007-04-25 2008-11-06 Akuatech S.R.L. Highly stable electrolytic water with reduced nmr half line width
WO2008131936A3 (en) * 2007-04-25 2009-10-01 Akuatech S.R.L. Highly stable electrolytic water with reduced nmr half line width
US8709495B2 (en) 2007-04-25 2014-04-29 Apr Nanotechnologies S.A. Highly stable electrolytic water with reduced NMR half line width
US9404192B2 (en) 2007-04-25 2016-08-02 Apr Nanotechnologies S.A. Highly stable electrolytic water with reduced NMR half line width
US9889153B2 (en) 2007-04-25 2018-02-13 Apr Nanotechnologies S.A. Highly stable electrolytic water with reduced NMR half line width
EP2082751A3 (en) * 2008-01-25 2009-09-23 Gian Battista Ceresa Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs
US8691289B2 (en) 2009-06-17 2014-04-08 Apr Nanotechnologies S.A. Methods of treating outer eye disorders using high ORP acid water and compositions thereof
CN101961103A (en) * 2009-07-25 2011-02-02 铜陵市九洲天然动植物产品有限公司 Method for preparing honeyed selenium-rich pine edible powder
CN101961103B (en) * 2009-07-25 2013-05-08 铜陵市九洲天然动植物产品有限公司 Method for preparing honeyed selenium-rich pine edible powder
IT201600103224A1 (en) * 2016-10-17 2018-04-17 Claudia Panizza PREPARATION OF THE BASIS FOR ACTIVE SUBSTANCES

Also Published As

Publication number Publication date
JP2008179594A (en) 2008-08-07
KR100890070B1 (en) 2009-03-27
KR20080070569A (en) 2008-07-30

Similar Documents

Publication Publication Date Title
WO2008091032A1 (en) Atopy eczema relaxant composition using natural material
CN105504966B (en) A kind of offset litho printing ink
CN105395467A (en) Traditional Chinese medicinal composition, skin-care cosmetic and application of skin-care cosmetic
CN104013878B (en) A kind of lavipeditum medicine vinegar and preparation method thereof for treating tinea pedis
CN104762136A (en) Compound tea tree essential oil with sterilization and disinfection effects and preparation method of compound tea tree essential oil
KR20070014988A (en) A cosmetic composition for atopian skin
KR100905437B1 (en) Composition for treating of atopic dermatitis and preparing method thereof
CN1633981A (en) Ion water beauty product and its face pack
KR102308571B1 (en) Functional cleaning agent containing sand pear extract
CN104436116B (en) A kind of rosemary lavipeditum powder and preparation method thereof
CN104414909A (en) Chitosan washing-free hand sanitizer
CN109431824B (en) Antibacterial deodorizing gel and application thereof
CN105194286B (en) Have effects that radiation protection and repair the external skin-care composition of skin barrier, essence and preparation method thereof
CN101129534A (en) Three-flower herpes medicine soup
CN110051793A (en) A kind of skin radiation injury protective agent and preparation method thereof
KR100855069B1 (en) Preparing method of atopy eczema relaxant composition using natural material
CN105434839B (en) Have effects that radiation protection and repair the external skin-care composition of skin barrier, gel and preparation method thereof
CN109925368A (en) A kind of skin care exfoliating cream of antibacterial tinea pedis-preventing
CN113576981A (en) Multi-effect natural no-clean hand sanitizer and preparation method thereof
CN106177264A (en) A kind of ultra micro bacterio static itching-relieving damp eliminating calcium preparation and its preparation method and application
CN105664438A (en) Indoor bodybuilding bicycle chair cushion set and bodybuilding bicycle with same
CN1552428A (en) External antifungal Chinese medicine composition
KR20080079396A (en) Medicine composition of atopic dermatitis using natural material
CN105996878B (en) A kind of Multifunctional domestic health care paper pumping
CN109045218A (en) A kind of Yao medicinal composition and preparation method thereof for preventing and treating inflammation of upper respiratory tract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07708699

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07708699

Country of ref document: EP

Kind code of ref document: A1